{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:14:39Z","timestamp":1790741679527,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["MR\/Y004051\/1"],"award-info":[{"award-number":["MR\/Y004051\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K015583\/1"],"award-info":[{"award-number":["MR\/K015583\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000320","name":"Alzheimer&apos;s Society","doi-asserted-by":"publisher","award":["569"],"award-info":[{"award-number":["569"]}],"id":[{"id":"10.13039\/501100000320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002283","name":"Alzheimer&apos;s Research UK","doi-asserted-by":"publisher","award":["ARUK-PPG2020A-009"],"award-info":[{"award-number":["ARUK-PPG2020A-009"]}],"id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.neuropharm.2026.111010","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:13:30Z","timestamp":1778825610000},"page":"111010","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Astrocytic reactivity and amyloid load are reduced in a sex-dependent manner in a mouse model of amyloid pathology following protease-activated receptor 2 activation"],"prefix":"10.1016","volume":"297","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1590-0545","authenticated-orcid":false,"given":"Nicole","family":"Edwards","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6796-411X","authenticated-orcid":false,"given":"Shuzo","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7213-0686","authenticated-orcid":false,"given":"Gail","family":"McConnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4145-9670","authenticated-orcid":false,"given":"Trevor J.","family":"Bushell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neuropharm.2026.111010_bib1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/13872877251411561","article-title":"The role of astrocytes in Alzheimer's disease: pathophysiology, biomarkers, and therapeutic potential","volume":"110","author":"Abedin","year":"2026","journal-title":"J. Alzheimers Dis."},{"issue":"15","key":"10.1016\/j.neuropharm.2026.111010_bib3","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1093\/bioinformatics\/btx180","article-title":"Trainable weka segmentation: a machine learning tool for microscopy pixel classification","volume":"33","author":"Arganda-Carreras","year":"2017","journal-title":"Bioinformatics"},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111010_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.tcb.2023.09.006","article-title":"Astrocyte morphology","volume":"34","author":"Baldwin","year":"2024","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.neuropharm.2026.111010_bib4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological staging of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111010_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/neurosci5010005","article-title":"The role of astrocytes and alpha-synuclein in Parkinson's disease: a review","volume":"5","author":"Brash-Arias","year":"2024","journal-title":"NeuroSci"},{"key":"10.1016\/j.neuropharm.2026.111010_bib8","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1742-2094-9-142","article-title":"Transient early neurotrophin release and delayed inflammatory cytokine release by microglia in response to PAR-2 stimulation","volume":"9","author":"Chen","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2026.111010_bib9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bbi.2024.09.022","article-title":"Astrocyte-neuron communication through the complement C3-C3aR pathway in Parkinson's disease","volume":"123","author":"Chi","year":"2025","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111010_bib10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41593-025-02115-w","article-title":"Astrocytic Sox9 overexpression in Alzheimer's disease mouse models promotes A\u03b2 plaque phagocytosis and preserves cognitive function","volume":"29","author":"Choi","year":"2026","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111010_bib11","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/s41593-024-01580-z","article-title":"A phenotypic screening platform for identifying chemical modulators of astrocyte reactivity","volume":"27","author":"Clayton","year":"2024","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111010_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/science.adc9020","article-title":"Molecular basis of astrocyte diversity and morphology across the CNS in health and disease","volume":"378","author":"Endo","year":"2022","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111010_bib13","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","article-title":"Reactive astrocyte nomenclature, definitions, and future directions","volume":"24","author":"Escartin","year":"2021","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111010_bib14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41597-021-01054-y","article-title":"Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer's disease","volume":"8","author":"Forner","year":"2021","journal-title":"Sci. Data"},{"issue":"10510","key":"10.1016\/j.neuropharm.2026.111010_bib15","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/S0140-6736(25)01329-7","article-title":"Treatment for Alzheimer's disease","volume":"406","author":"Fox","year":"2025","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111010_bib16","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1476-5381.2011.01293.x","article-title":"Indirect modulation of neuronal excitability and synaptic transmission in the hippocampus by activation of proteinase-activated receptor-2","volume":"163","author":"Gan","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111010_bib17","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1124\/jpet.108.142570","article-title":"Identification and characterization of novel small-molecule protease-activated receptor 2 agonists","volume":"327","author":"Gardell","year":"2008","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111010_bib18","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.3233\/JAD-231112","article-title":"Vulnerability of spatial pattern separation in 5xFAD Alzheimer's disease mouse model","volume":"97","author":"Gephine","year":"2024","journal-title":"J. Alzheimers Dis."},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111010_bib19","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.stemcr.2024.07.002","article-title":"Induction of astrocyte reactivity promotes neurodegeneration in human pluripotent stem cell models","volume":"19","author":"Gomes","year":"2024","journal-title":"Stem Cell Rep."},{"issue":"20","key":"10.1016\/j.neuropharm.2026.111010_bib21","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.3390\/cells13201724","article-title":"Sex differences in astrocyte activity","volume":"13","author":"Gozlan","year":"2024","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111010_bib22","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1471-4159.2010.06737.x","article-title":"Astrocytic activation and an inhibition of MAP kinases are required for proteinase-activated receptor-2-mediated protection from neurotoxicity","volume":"113","author":"Greenwood","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2026.111010_bib23","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41593-020-0624-8","article-title":"Disease-associated astrocytes in Alzheimer's disease and aging","volume":"23","author":"Habib","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111010_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106489","article-title":"Sex-specific vulnerabilities in human astrocytes underpin the differential impact of palmitic acid","volume":"195","author":"Hidalgo-Lanussa","year":"2024","journal-title":"Neurobiol. Dis."},{"issue":"6286","key":"10.1016\/j.neuropharm.2026.111010_bib25","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111010_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70299","article-title":"Astrocyte in neurological disease: pathogenesis and therapy","volume":"6","author":"Huang","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.neuropharm.2026.111010_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2025.1665802","article-title":"The transcriptional and cellular landscape of cognitive resilience to Alzheimer's disease","volume":"18","author":"Khera","year":"2025","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111010_bib28","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3390\/ijms26010410","article-title":"A new strategy in modulating the protease-activated receptor 2 (PAR2) in autoimmune diseases","volume":"26","author":"Khoon","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111010_bib29","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1523\/JNEUROSCI.0407-21.2021","article-title":"Human astrocytes exhibit tumor Microenvironment-, Age-, and sex-related transcriptomic signatures","volume":"42","author":"Krawczyk","year":"2022","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111010_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.870085","article-title":"Proteomic alterations and novel markers of neurotoxic reactive astrocytes in human induced pluripotent stem cell models","volume":"15","author":"Labib","year":"2022","journal-title":"Front. Mol. Neurosci."},{"issue":"15","key":"10.1016\/j.neuropharm.2026.111010_bib31","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.3390\/ijms26157556","article-title":"Bidirectional interplay between microglia and mast cells","volume":"26","author":"Lakatos","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111010_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1421455","article-title":"Erlotinib regulates short-term memory, tau\/A\u03b2 pathology, and astrogliosis in mouse models of AD","volume":"15","author":"Lee","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111010_bib33","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.1038\/s41467-025-62995-1","article-title":"Astrocyte priming enhances microglial A\u03b2 clearance and is compromised by APOE4","volume":"16","author":"Lee","year":"2025","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111010_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae396","article-title":"Glial fibrillary acidic protein in Alzheimer's disease: a narrative review","volume":"6","author":"Leipp","year":"2024","journal-title":"Brain Commun."},{"key":"10.1016\/j.neuropharm.2026.111010_bib35","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.it.2020.07.006","article-title":"Microglia and astrocytes in disease: dynamic duo or partners in crime?","volume":"41","author":"Liddelow","year":"2020","journal-title":"Trends Immunol."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111010_bib36","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.neuron.2018.10.031","article-title":"Complement C3aR inactivation attenuates tau pathology and reverses an immune network deregulated in tauopathy models and Alzheimer's disease","volume":"100","author":"Litvinchuk","year":"2018","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111010_bib37","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/s41593-018-0209-y","article-title":"DeepLabCut: markerless pose estimation of user-defined body parts with deep learning","volume":"21","author":"Mathis","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111010_bib38","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.18659","article-title":"A novel optical microscope for imaging large embryos and tissue volumes with sub-cellular resolution throughout","volume":"5","author":"McConnell","year":"2016","journal-title":"eLife"},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111010_bib39","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1042\/BST20200191","article-title":"The development of proteinase-activated receptor-2 modulators and the challenges involved","volume":"48","author":"McIntosh","year":"2020","journal-title":"Biochem. Soc. Trans."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111010_bib40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1146\/annurev-pathmechdis-042624-114332","article-title":"Basic microglial functions and how they Go awry in neurodegenerative disease","volume":"21","author":"McKinney","year":"2026","journal-title":"Annu. Rev. Pathol."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111010_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114278","article-title":"Hippocampal astrocytes induce sex-dimorphic effects on memory","volume":"43","author":"Meadows","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2026.111010_bib43","doi-asserted-by":"crossref","DOI":"10.1177\/23982128251345673","article-title":"Neuroprotection induced by protease-activated receptor 2 activation is independent of Gq signalling","volume":"9","author":"Moudio","year":"2025","journal-title":"Brain Neurosci. Adv."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111010_bib42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00213-021-06040-1","article-title":"Protease-activated receptor 2 activation induces behavioural changes associated with depression-like behaviour through microglial-independent modulation of inflammatory cytokines","volume":"239","author":"Moudio","year":"2022","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.neuropharm.2026.111010_bib44","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2303809120","article-title":"Astrocyte-targeting therapy rescues cognitive impairment caused by neuroinflammation via the Nrf2 pathway","volume":"120","author":"Nakano-Kobayashi","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"40","key":"10.1016\/j.neuropharm.2026.111010_bib45","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111010_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.713726","article-title":"Comprehensive evaluation of the 5XFAD mouse model for preclinical testing applications: a MODEL-AD study","volume":"13","author":"Oblak","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111010_bib48","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41582-023-00822-1","article-title":"Functional roles of reactive astrocytes in neuroinflammation and neurodegeneration","volume":"19","author":"Patani","year":"2023","journal-title":"Nat. Rev. Neurol."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111010_bib47","doi-asserted-by":"crossref","first-page":"6766","DOI":"10.3390\/ijms25126766","article-title":"Behaviour hallmarks in Alzheimer's disease 5xFAD mouse model","volume":"25","author":"P\u00e1dua","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111010_bib49","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.3390\/cells10071812","article-title":"The complement system: a powerful modulator and effector of astrocyte function in the healthy and diseased central nervous system","volume":"10","author":"Pekna","year":"2021","journal-title":"Cells"},{"issue":"Pt 8","key":"10.1016\/j.neuropharm.2026.111010_bib50","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1093\/brain\/awt171","article-title":"Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology","volume":"136","author":"Perez-Nievas","year":"2013","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111010_bib51","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1111\/ejn.14688","article-title":"Mitogen-activated protein kinase phosphatase-2 deletion modifies ventral tegmental area function and connectivity and alters reward processing","volume":"52","author":"Pytka","year":"2020","journal-title":"Eur. J. Neurosci."},{"issue":"14","key":"10.1016\/j.neuropharm.2026.111010_bib52","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1016\/j.neuron.2023.04.018","article-title":"A dynamical systems approach for multiscale synthesis of Alzheimer's pathogenesis","volume":"111","author":"Rollo","year":"2023","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111010_bib53","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12974-021-02158-3","article-title":"Crosstalk between astrocytes and microglia results in increased degradation of \u03b1-synuclein and amyloid-\u03b2 aggregates","volume":"18","author":"Rostami","year":"2021","journal-title":"J. Neuroinflammation"},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111010_bib55","article-title":"A combinatory approach of semi-automatic labeling and long short-term memory to classify behavioral syllables","volume":"10","author":"SaLSa","year":"2023","journal-title":"eNeuro"},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111010_bib56","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/nm.4397","article-title":"Microglia emerge as central players in brain disease","volume":"23","author":"Salter","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2026.111010_bib57","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.physbeh.2014.05.041","article-title":"Behavioral and EEG changes in male 5xFAD mice","volume":"135","author":"Schneider","year":"2014","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2026.111010_bib59","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"TRAILBLAZER-ALZ 2 investigators. Donanemab in early symptomatic alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111010_bib54","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.3390\/jcm10091809","article-title":"Depression as a risk factor for Alzheimer's disease: a systematic review of longitudinal meta-analyses","volume":"10","author":"S\u00e1iz-V\u00e1zquez","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.neuropharm.2026.111010_bib60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111010_bib61","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13195-023-01308-4","article-title":"Stress, depression, and risk of dementia - a cohort study in the total population between 18 and 65 years old in region Stockholm","volume":"15","author":"Wallensten","year":"2023","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neuropharm.2026.111010_bib63","article-title":"Emerging pathological mechanisms of Alzheimer's disease pathogenesis: from neuroimmune interactions to intercellular communication","volume":"18","author":"Wang","year":"2026","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111010_bib62","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12974-024-03046-2","article-title":"Dimethyl fumarate improves cognitive impairment and neuroinflammation in mice with Alzheimer's disease","volume":"21","author":"Wang","year":"2024","journal-title":"J. Neuroinflammation"},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111010_bib64","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3390\/biom14101294","article-title":"Comprehensive analysis of the 5xFAD mouse model of Alzheimer's disease using dMRI, immunohistochemistry, and neuronal and glial functional metabolic mapping","volume":"14","author":"Westi","year":"2024","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111010_bib65","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.celrep.2019.07.060","article-title":"Complement C3 is activated in human AD brain and is required for neurodegeneration in mouse models of amyloidosis and tauopathy","volume":"28","author":"Wu","year":"2019","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111010_bib66","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1002\/alz.12899","article-title":"Resilience and resistance to the accumulation of amyloid plaques and neurofibrillary tangles in centenarians: an age-continuous perspective","volume":"19","author":"Zhang","year":"2023","journal-title":"Alzheimer's Dement."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111010_bib67","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13024-024-00712-0","article-title":"Updates on mouse models of Alzheimer's disease","volume":"19","author":"Zhong","year":"2024","journal-title":"Mol. Neurodegener."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826001838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826001838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:37:04Z","timestamp":1783093024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826001838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":63,"alternative-id":["S0028390826001838"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111010","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Astrocytic reactivity and amyloid load are reduced in a sex-dependent manner in a mouse model of amyloid pathology following protease-activated receptor 2 activation","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111010"}}